Physician

Steven Lawrence Rosinski, MD, PHD

According to 2025 Medicare claims, Steven Rosinski, MD, PHD (NPI: 1073621819) practices hematology/oncology in the Lake Havasu City-Kingman, AZ market, with the plurality of this provider's patient population coming from Mohave, AZ. This provider's primary affiliated billing organization is PHOENIX CANCER AND BLOOD DISORDER TREATMENT INSTITUTE PLLC (NPI: 1255819736; TIN: 831215315) and primary practice location at 86442-9998.

Rosinski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 625 traditional Medicare patients, billed 209,941 HCPCS/CPT codes, and received $3,076,962 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,519 prescription claims across 434 beneficiaries totaling $3,409,447 in drug costs, led by Revlimid (Lenalidomide). DME data shows 86 claims. Open Payments data shows 89 records totaling $2,520. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $17,254 to $3,076,962. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,447 to $3,409,447. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $292 to $75,793.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	27	220	$17,254
2016	20	49	$3,935
2017	106	9,142	$149,538
2018	361	77,144	$1,102,219
2019	286	129,066	$1,202,318
2020	399	128,355	$1,933,514
2021	524	166,371	$2,229,383
2022	675	263,690	$3,016,741
2023	752	282,217	$3,241,568
2024	625	209,941	$3,076,962

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	19	26	$4,447
2018	95	343	$900,499
2019	132	604	$1,308,583
2020	156	879	$1,839,794
2021	265	1,452	$1,914,019
2022	384	2,394	$3,044,033
2023	436	2,503	$4,258,571
2024	434	2,519	$3,409,447

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	53	$8,049
2019	N/R	83	$10,688
2020	N/R	N/R	N/R
2021	N/R	34	$1,828
2022	N/R	43	$2,443
2023	N/R	64	$3,270
2024	N/R	86	$2,773

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	73	73	$155
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	104	104	$112
96413	Administration of chemotherapy into vein, 1 hour or less	92	556	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	260	1,040	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	356	637	$63

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	50	1,379	$960,195
Jakafi	Ruxolitinib Phosphate	31	930	$526,981
Cabometyx	Cabozantinib S-Malate	14	420	$352,660
Lenalidomide	Lenalidomide	25	610	$282,240
Bosulif	Bosutinib	14	392	$132,175

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	15	$1,065
A4349	Male external catheter, with or without adhesive, disposable, each	N	N/R	11	$709
J8521	Capecitabine, oral, 500 mg	N	N/R	11	$275
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	15	$228
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	89	$2,520	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Steven Lawrence Rosinski, MD, PHD?

Tedicare shows public-source Medicare data for Steven Lawrence Rosinski, MD, PHD (NPI 1073621819), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven Lawrence Rosinski, MD, PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Steven Lawrence Rosinski, MD, PHD?

Steven Lawrence Rosinski, MD, PHD is linked to PHOENIX CANCER AND BLOOD DISORDER TREATMENT INSTITUTE PLLC (billing NPI 1255819736) in the available physician profile data.

Does Steven Lawrence Rosinski, MD, PHD have Open Payments data?

Steven Lawrence Rosinski, MD, PHD has 89 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.